Brenton Scott
Oprichter bij Pulmotect, Inc.
Vermogen: 5 M $ op 30-04-2024
Profiel
Brenton Scott has founded two companies, Bondwell Technologies, Inc. in 2017 and Pulmotect, Inc. in 2007, where he holds the title of President & Chief Operating Officer.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-02-2023 | 21 185 283 ( 25.41% ) | 5 M $ | 30-04-2024 |
Actieve functies van Brenton Scott
| Bedrijven | Functie | Begin |
|---|---|---|
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Oprichter | 01-01-2007 |
Eerdere bekende functies van Brenton Scott
| Bedrijven | Functie | Einde |
|---|---|---|
Bondwell Technologies, Inc.
 Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Health Technology |
